Hydrogen Nanoparticles Reduce PTSD Anxiety in Rats
- Authors
- Lanxia Wu, Congwen Yang, Yiqin Ding, Xinru Liu, Hao Sun, Xue Li, Yining Lu, Lifen Liu, Qingyang Fu, Min Li, Yingshuai Wang, Yuehan Zhao, Wenhao Han, Guohua Lu, Lin Sun
- Journal
- Molecular Neurobiology
- Year
- 2025
- DOI
- 10.1007/s12035-025-05524-x
- Study Type
- Rat
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Post-Traumatic Stress Disorder
- Body System
- Nervous System
TL;DR
Magnesium hydrosilicide nanosheets (MSN) delivering sustained hydrogen reversed anxiety-like behavior and synaptic deficits in a PTSD rat model by downregulating NLRP3 inflammasome and restoring BDNF/PSD95 levels.
Key Finding
In rats with trauma-induced anxiety, a 7-day treatment with hydrogen-releasing nanoparticles significantly reduced anxiety-like behaviors and restored damaged brain cell connections in the prefrontal cortex.
Summary
Researchers tested a special nanoparticle (a tiny particle made of magnesium and hydrogen) that releases hydrogen slowly in rats exposed to traumatic stress. The treatment reduced anxiety-like behaviors and restored damage to brain connections in the prefrontal cortex (the thinking and emotion-control part of the brain). The hydrogen appeared to work by reducing inflammation and protecting the structure of brain synapses (the connections between brain cells).
Practical Takeaway
This is early-stage research in animals only, so it cannot yet tell us whether hydrogen would help people with PTSD. The study suggests hydrogen may have anti-inflammatory and brain-protective effects that warrant further investigation, but human trials would be needed before any therapeutic claims could be made.
Abstract
Post-traumatic stress disorder (PTSD) is a complex psychiatric disorder closely related to stress and traumatic events. Neuroinflammation and synaptic plasticity may play a role in the neurophysiological mechanisms of anxiety-like behaviors in PTSD. In this study, a novel magnesium hydrosilicide nanosheet (MSN) with anti-inflammatory and antioxidant properties was developed as a potential intervention for behavioral disorders associated with PTSD. Sustained hydrogen release was achieved through an optimized dosing regimen in a rat model subjected to single prolonged stress and electric foot shock (SPS&S), a validated paradigm for PTSD induction. Experimental results showed that a 7-day MSN intervention significantly attenuated anxiety-like behaviors while reversing the synaptic deficits induced by SPS&S in prefrontal cortical regions. Molecular analyses showed a concomitant downregulation of NOD-like receptor protein 3 (NLRP3) inflammasome components (protein as well as RNA levels) and restoration of neuroplasticity markers including brain-derived neurotrophic factor (BDNF) and postsynaptic density protein 95 (PSD95) protein levels. The therapeutic outcome correlated with the dual ability of hydrogen to inhibit pro-inflammatory signaling cascades and protect synaptic structures. These findings suggest that MSN-mediated hydrogen delivery is an effective strategy to address PTSD-associated affective dysfunction by orchestrating neuroimmune responses and synaptic homeostasis.